Bryn Mawr Trust Advisors LLC Acquires Shares of 2,036 Teleflex Incorporated $TFX

Bryn Mawr Trust Advisors LLC bought a new position in Teleflex Incorporated (NYSE:TFX) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,036 shares of the medical technology company’s stock, valued at approximately $241,000.

A number of other institutional investors and hedge funds have also made changes to their positions in TFX. Banque Cantonale Vaudoise acquired a new stake in Teleflex in the first quarter valued at about $27,000. Costello Asset Management INC purchased a new position in shares of Teleflex during the 1st quarter worth approximately $28,000. Brooklyn Investment Group raised its stake in shares of Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after buying an additional 150 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in shares of Teleflex by 242.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock valued at $26,000 after buying an additional 153 shares during the period. Finally, Allworth Financial LP boosted its stake in shares of Teleflex by 504.8% in the first quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock valued at $34,000 after buying an additional 212 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Stock Up 0.8%

TFX opened at $109.39 on Friday. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The firm has a market cap of $4.83 billion, a P/E ratio of 25.74, a PEG ratio of 1.79 and a beta of 1.05. Teleflex Incorporated has a 52 week low of $102.58 and a 52 week high of $200.15. The business’s fifty day simple moving average is $125.66 and its 200 day simple moving average is $123.07.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.2%. Teleflex’s dividend payout ratio is presently -18.50%.

Analysts Set New Price Targets

Several research analysts have issued reports on TFX shares. Weiss Ratings reiterated a “sell (d+)” rating on shares of Teleflex in a research report on Wednesday, October 8th. Royal Bank Of Canada lowered their price target on shares of Teleflex from $135.00 to $120.00 and set a “sector perform” rating on the stock in a research note on Friday. Mizuho raised their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a research note on Friday, August 1st. Wall Street Zen downgraded shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. Finally, Zacks Research cut shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. One analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $137.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.